What is the current Price Target for the Aslan Pharmaceuticals Ltd. ADR stock?

The average Aslan Pharmaceuticals Ltd. ADR target price is $72.00. This is 11,900.00% higher than the current stock price. 1 Analyst has issued a Aslan Pharmaceuticals Ltd. ADR price target 2025.

How high will the Aslan Pharmaceuticals Ltd. ADR stock rise?

No reliable answer can be given as to how high the Aslan Pharmaceuticals Ltd. ADR stock will rise. The performance of stocks, including the Aslan Pharmaceuticals Ltd. ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Aslan Pharmaceuticals Ltd. ADR stock today?

The performance of Aslan Pharmaceuticals Ltd. ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Aslan Pharmaceuticals Ltd. ADR stock fall?

The decline in Aslan Pharmaceuticals Ltd. ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Aslan Pharmaceuticals Ltd. ADR Forecast, price target & analysts

$0.60

0.00%

Nasdaq, Fri, Nov 15 2024

ISIN

US04522R1014

Symbol

ASLN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Aslan Pharmaceuticals Ltd. ADR Target price 2024 - Analyst rating & recommendation

Aslan Pharmaceuticals Ltd. ADR Classifications & Recommendation:

Buy

100%

Aslan Pharmaceuticals Ltd. ADR Price Target

Target Price	$72.00
Price	$0.60
Potential	11,900.00% register free of charge
Number of Estimates	1

	1 Analyst has issued a Aslan Pharmaceuticals Ltd. ADR price target 2025. The average Aslan Pharmaceuticals Ltd. ADR target price is $72.00. This is 11,900.00% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 1 Analysts recommend Aslan Pharmaceuticals Ltd. ADR to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Aslan Pharmaceuticals Ltd. ADR stock has an average upside potential 2025 of 11,900.00% register free of charge . Most analysts recommend the Aslan Pharmaceuticals Ltd. ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-21.51	-10.24
	484.51%	52.39%
P/E		negative

The average Aslan Pharmaceuticals Ltd. ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

2023	$-21.51	484.51%
2024	$-10.24 52.39% Unlock

Current	-0.04	88.89%
2024	-0.06 50.00% Unlock

Aslan Pharmaceuticals Ltd. ADR...

Discover more stocks with a high price target

Valneva 259.22%

CureVac N.V. 175.41%

Moderna 119.67%

Plug Power Inc. 90.51%

Bavarian Nordic 87.82%

BioNTech SE - ADR 36.41%

RWE 35.54%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now